[Analysis on the Incidence and Economic Burden of Patients with Lung Cancer]

Zhongguo Fei Ai Za Zhi. 2022 Mar 20;25(3):167-173. doi: 10.3779/j.issn.1009-3419.2022.101.09.
[Article in Chinese]

Abstract

Background: The previous study has indicated that lung cancer has a high incidence and mortality in China, and has caused a large economic burden. The purpose of this study was to analyze the incidence and economic burden of lung cancer by analyzing the information on the home page of discharge history of lung cancer patients in Hebei Tumor Hospital, and to provide scientific basis for the prevention and treatment of lung cancer.

Methods: The information of all of the discharges, new cases, surgical patients, age, gender, length of stay and hospitalization cost of lung cancer patients in Hebei Tumor Hospital from January 2012 to December 2019 were retrieved based on the medical record management system, and the incidence trend, gender and age distribution as well as the economic burden of the disease were statistically described.

Results: The number of new cases of lung cancer increased year by year, from 2,235 cases in 2012 to 5,012 cases in 2019. The number of males always outnumbered females, but the gender ratio decreased year by year, from 2.25 in 2012 to 1.56 in 2019. Among new cases of lung cancer, the proportion of surgical treatment increased year by year, from 28.14% in 2012 to 44.83% in 2019. Except for 2012, the proportion of surgical operations in female patients was higher than that in male patients from 2013 to 2019. The proportion of surgical operations in male and female patients was 23.52% and 28.07% in 2013, and 36.14% and 58.37% in 2019, respectively. The median age at the onset of lung cancer has increased year by year, from 61 years old in 2012 to 63 years old in 2019. The median age of onset in all lung cancer patients was higher in males than in females. The number of new lung cancer patients and surgical patients both showed an increasing trend with the increase of age, and both reached the maximum value in the age group of 60-69 years old. With the increase of age, the number of patients gradually decreased. The median length of hospital stay for all discharged lung cancer patients or surgical patients decreased year by year, from 10 d and 19 d in 2012 to 8 d and 17 d in 2019, respectively, while the median hospitalization cost increased year by year. It increased from 10,611.46 yuan and 38,750.13 yuan in 2012 to 17,187.15 yuan and 84,030.16 yuan in 2019, respectively.

Conclusions: Lung cancer is still one of the main cancers endangering the health of Chinese residents. The incidence of lung cancer is increasing year by year, and the distribution of gender and age has certain characteristics. In order to reduce the number of cases and the economic burden, effective prevention and control measures should be formulated and medical reform should be strengthened.

【中文题目:肺癌患者发病情况和经济负担的分析】 【中文摘要:背景与目的 肺癌在我国具有较高的发病率和致死率,并造成了较大的经济负担,本研究旨在通过分析河北省肿瘤医院肺癌患者出院病历首页的相关信息,研究肺癌的发病情况和经济负担,为肺癌的防治研究提供科学依据。方法 基于病案管理系统检索出2012年1月-2019年12月河北省肿瘤医院肺癌患者的出院人次、新发人数、手术人数、年龄、性别、住院天数和住院费用等信息,统计描述肺癌患者发病趋势、性别和年龄分布以及疾病的经济负担。结果 肺癌新发人数逐年增加,2012年肺癌新发2,235人,2019年为5,012人。发病人数男性始终大于女性,但男女性别比逐年降低,由2012年的2.25降至2019年的1.56。肺癌新发人数中手术治疗的比例逐年增加,由2012年的28.14%增长到2019年的44.83%。除2012年外,2013年-2019年女性患者的手术比例均高于男性,并且逐年增加,2013年新发肺癌男女患者的手术比例分别为23.52%和28.07%,2019年分别为36.14%和58.37%。肺癌患者的中位发病年龄逐年增长,2012年新发肺癌患者的中位年龄为61岁,2019年为63岁。全部肺癌患者的中位发病年龄,男性均大于女性。肺癌新发患者和手术患者的人数都显示出随着年龄的增长而增加的趋势,且均在60岁-69岁的年龄组段达到最大值,随着年龄的增长,患者人数逐渐减少,所有年龄组段的发病人数也逐年增加。所有出院人次的肺癌患者和手术患者的中位住院天数逐年减少,分别由2012年的10 d和19 d降低至2019年的8 d和17 d,而中位住院费用逐年升高,分别由2012年的10,611.46元和38,750.13元增长到2019年的17,187.15元和84,030.16元。结论 肺癌仍是危害我国居民健康的主要癌种之一,发病人数逐年增加,性别和年龄分布具有一定的特征,应制定有效的防控措施,加强医疗改革,减少发病人数和经济负担。 】 【中文关键词:肺肿瘤;性别;年龄;住院天数;住院费用】.

Keywords: Age; Days of hospitalization; Gender; Hospital costs; Lung neoplasms.

MeSH terms

  • Age Distribution
  • Aged
  • China / epidemiology
  • Female
  • Financial Stress*
  • Humans
  • Incidence
  • Lung Neoplasms* / epidemiology
  • Lung Neoplasms* / surgery
  • Male
  • Middle Aged